US Broker Ratings

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the Future of RNA-Targeted Therapeutics with Promising Forward P/E

For investors keen on the biotechnology sector, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a company worth watching due to its cutting-edge research in RNA-targeted therapeutics and gene therapies. Although navigating..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 32% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline of cancer therapies and a striking analyst consensus that forecasts a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, TG Therapeutics, Inc. (NASDAQ: TGTX) offers an intriguing opportunity. This biopharmaceutical company, with its focus on innovative treatments for B-cell..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a Potential 42% Upside in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the precision oncology sector, is capturing investor attention with a potential upside of 42.06%, according to analyst ratings. As a company..

Rhythm Pharmaceuticals (RYTM): Analyst Consensus Suggests 55% Upside Potential for Investors

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of the biotechnology sector with a targeted focus on rare neuroendocrine diseases. With a market capitalization of $6.06 billion, this Boston-based..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 101% Potential Upside in Biotech Innovation

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is making waves with its innovative approach to radiopharmaceuticals. With a market cap of $3.64 billion, this Australia-based company..

Legend Biotech Corporation (LEGN): Analyst Consensus Reveals 170% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, positioning itself at the forefront of innovative cancer treatments. Headquartered in Somerset, New Jersey, this biopharmaceutical company..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: A Medical Device Innovator with 11.32% Potential Upside

Glaukos Corporation (NYSE: GKOS), a pioneering name in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions targeting glaucoma, corneal disorders, and retinal..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotech sector, Corcept Therapeutics Incorporated (CORT) presents a compelling case with its current market dynamics and growth prospects. Specializing in the development of medications..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 33.77% Potential Upside in Medical Device Innovation

TransMedics Group, Inc. (NASDAQ: TMDX), a pivotal player in the healthcare sector, specifically within the medical devices industry, is garnering attention with its innovative approach to organ transplant therapy. The..

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a Promising 14.51% Upside Potential for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a trailblazer in the biotechnology sector, has caught the attention of investors with its focus on developing genetic medicines for conditions with significant unmet medical..

Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating a 14.55% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, and boasting a market..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A 39% Potential Upside in the Biotech Arena

Cytokinetics, Incorporated (NASDAQ: CYTK) stands as a compelling player in the biotechnology sector, primarily focusing on pioneering treatments for debilitating muscular and cardiac diseases. As the company navigates the competitive..

Ionis Pharmaceuticals (IONS): Investor Outlook on a Biotech Innovator with 27.76% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out as a compelling player in the biotechnology sector, promising significant potential upside for investors intrigued by its innovative pipeline of RNA-targeted medicines. With..

RadNet, Inc. (RDNT) Investor Outlook: A 52.96% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) presents a compelling opportunity for investors with its robust position in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Los Angeles, California,..

Exact Sciences Corporation (EXAS) Investor Outlook: Analyzing the Growth Potential and Analyst Consensus

Exact Sciences Corporation (NASDAQ: EXAS) has positioned itself as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $20.03 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds